Previous studies have reported that the over-expression of CKMT1A was related to acute myeloid leukemia (AML), breast cancer, hepatocellular carcinoma (HCC), neck squamous cell carcinoma and nasopharyngeal carcinoma [15–19]. This evidence concerns the gene CKMT1A and nasopharyngeal carcinoma.